CHOLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Choline, and what generic alternatives are available?
Choline is a drug marketed by Decatur, Mcprf, Ucsf Rodiopharm, Univ Tx Md Anderson, and Wa Univ Sch Med. and is included in five NDAs.
The generic ingredient in CHOLINE is choline c-11. There are one hundred and two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the choline c-11 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Choline
A generic version of CHOLINE was approved as choline c-11 by MCPRF on September 12th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHOLINE?
- What are the global sales for CHOLINE?
- What is Average Wholesale Price for CHOLINE?
Summary for CHOLINE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| DailyMed Link: | CHOLINE at DailyMed |
US Patents and Regulatory Information for CHOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Decatur | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 206319-001 | Nov 13, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Univ Tx Md Anderson | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 205690-001 | Oct 29, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mcprf | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 203155-001 | Sep 12, 2012 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
